CeeMCee Pharma Consulting SRL
The score of CeeMCee Pharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +67 % Total assets +69 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CeeMCee Pharma Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 62,418 € | ||||
| Equity | 237,984 € | ||||
| Cash | 211,369 € | ||||
| EBITDA | 93,242 € | ||||
| Total assets | 281,777 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 May 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 06 May 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 14 Apr 2022
CeeMCee Pharma Consulting's financial analysis
- Solvency84.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CeeMCee Pharma Consulting
CeeMCee Pharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0525.652.007
- VAT number
- BE0525652007
- Peppol
- Registered · 0208:0525652007 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Apr 2013
- Registered office
- 2980 Zoersel
- Latest accounts
- 2025 · filed on 21 May 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
CeeMCee Pharma Consulting (SRL) has been based in Zoersel since 2013, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 62,418 € and equity of 237,984 €; its revenue is not published. Its solvency stands at 84.5%, above the median of its sector (60.4%).
Companies similar to CeeMCee Pharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Docteur N Sarlet Research and experimental development on natural sciences and engineering Verviers · balance sheet 283,689 €
- Squipp Research and experimental development on natural sciences and engineering Woluwe-Saint-Pierre · balance sheet 285,562 €
- BIO-MI Research and experimental development on natural sciences and engineering Hove · balance sheet 277,375 €
- Hikamaja BV Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 289,444 €
- Duurzaam Repareren Belgium Research and experimental development on natural sciences and engineering Antwerp · balance sheet 273,963 €
Frequently asked questions about CeeMCee Pharma Consulting
What is the revenue of CeeMCee Pharma Consulting?
CeeMCee Pharma Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CeeMCee Pharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0525652007 for CeeMCee Pharma Consulting, if the company is VAT-registered. Its company number (CBE) is 0525.652.007.
Where is the registered office of CeeMCee Pharma Consulting?
According to the CBE register, the registered office of CeeMCee Pharma Consulting is in 2980 Zoersel.
What is the equity of CeeMCee Pharma Consulting?
At the close of the 2025 financial year, the equity of CeeMCee Pharma Consulting amounts to 237,984 €, a solvency of 84.5% of total assets.
Who manages CeeMCee Pharma Consulting?
The register lists 1 active mandates at CeeMCee Pharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CeeMCee Pharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →